Loading Events

USAIC’s 14th Annual BioPharma & Healthcare Summit

USAIC’s 14th annual BioPharma & Healthcare Summit Date: Tuesday, May 5 Marriott Cambridge, Kendall Square, Massachusetts Register online at www.usaindiachamber.org Chair & Emcee (5th consecutive year): Andrew Plump, President of R&D, Takeda Pharmaceuticals Summit Theme: “From N of One to N of a Billion” 250+ CEOs, senior R&D leaders, CMOs of Big & Emerging Global BioPharma companies and Academic Leaders participating Global Leaders and R&D Heads: Roy Vagelos, Retired Chairman & CEO, Merck & Co; Stelios Papadopoulos, Chairman, Biogen; Stanley Crooke, Executive Chairman, Ionis; Christopher Viehbacher, Managing Director, Gurnet Point Capital; Mathai Mammen, Global Head of R&D, Janssen Pharmaceutical- J&J; James Bradner, President, Novartis Institutes for BioMedical Research; Sanat Chattopadhyay, President, Merck Manufacturing Division, Merck & Co; David Meeker, CEO, KSQ Therapeutics; George Church, Professor of Genetics, Harvard Medical School; Al Sandrock, Head of R&D, Biogen; Philip Larsen, Global Head of Research, Bayer Pharma; Dhaval Patel, Chief Scientific Officer, UCB Some of the Participants & Speakers: Jose Baselga, President, Oncology R&D, AstraZeneca; Rehan Verjee, President, EMD Serono; Marcela Maus, Director of Cellular Immunotherapy, MGH Cancer Center; Najat Khan, COO, Janssen R&D Data Sciences; Michel Sadelain, Memorial Sloan Kettering Cancer Center; Alise Reicin, Former President, Global Clinical Dev, Celgene; Anne Heatherington, Head of Data Sciences Institute, Takeda; Nina Kjellson, General Partner, Canaan; Ansbert Gadicke, Managing Director, MPM Capital; Hari Bhartia, Co-Chairman, Jubilant Life Sciences; Bruce Chabner, Director of Clinical Research, MGH Cancer Center; Daniel Curran, Head, Rare Diseases, Takeda; Arpa Garay, President-Commercial Analytics, Merck & Co; Stanley Shaw, Associate Dean, Harvard Medical School; Timothy Yu, Boston Children’s Hospital; Simba Gill, CEO, Evelo; Paul Sekhri, CEO, eGenesis; Samarth Kulkarni, CEO, CRISPR Therapeutics; Barry Bloom, former Dean, Harvard School of Public Health; Rajeev Venkayya, President-Global Vaccine, Takeda; Sandip Agarwala, Managing Director, Longitude Capital; Joseph Pearlberg, Vice President, Deerfield Management; Raj Kannan, CEO, Chiasma; Tim Clackson, President, Akrevia; Frederic Chereau, CEO, LogicBio Networking Tea Breaks, Hosted Lunch, Cocktails & Networking Reception Panel Discussions & Keynotes covering • Drug Discovery & Development • Oncology • Rare Diseases • Digital & Data Sciences • Value & Access • Clinical Trials • Licensing, IP & Regulatory • BioPharma Investment Trends • Industry-Academic Research Partnerships Strategy Sessions (by invitation only): External Research & Partnering Strategies Digital & Data Sciences Register online at www.usaindiachamber.org Limited Seats. Registration rates will go up soon

Details

Date:
September 4, 2020
Time:
8:45 am - 6:15 pm
Website:
https://usaindiachamber.org/speaker.php

Location

Venue:
Boston Marriott Cambridge
50 Broadway
Cambridge, MA 02142

Organizer

Takeda Pharmaceutical Company Limited
Phone:
617-679-7000
Website:
https://www.takeda.com/